Issue |
Natl Sci Open
Volume 1, Number 1, 2022
Special Topic: COVID-19: Virus, Immunity and Vaccines
|
|
---|---|---|
Article Number | 20220017 | |
Number of page(s) | 2 | |
Section | Life Sciences and Medicine | |
DOI | https://doi.org/10.1360/nso/20220017 | |
Published online | 28 April 2022 |
- Sun Q, Chen W. Cell-in-cell: an emerging player in COVID-19 and immune disorders. Natl Sci Open 2022; 1: 20220001. [Article] [CrossRef] [Google Scholar]
- Ni L, Ye F, Cheng ML, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity 2020; 52: 971-977.e3. [Article] [CrossRef] [PubMed] [Google Scholar]
- Zhang L. Broadly neutralizing antibodies against SARS-CoV-2 variants. Natl Sci Open 2022; 1: 20220005. [Article] [CrossRef] [Google Scholar]
- Ni L, Ye F, Qiao Q, et al. Anti-viral memory T cell responses in the absence of IGG production in a COVID-19 convalescent individual. Natl Sci Open 2022; 1: 20220009. [Article] [CrossRef] [Google Scholar]
- Cheng ML, Zhao H, Qin CF. One year of COVID-19 vaccination. Natl Sci Open 2022; 1: 20220007. [Article] [CrossRef] [Google Scholar]
- Lin Y, Huang A. Towards robust immune responses after heterologous COVID-19 vaccination and its application perspectives. Natl Sci Open 2022; 1: 20220008. [Article] [CrossRef] [Google Scholar]
- Jia S, Zhu W, Jiang H, et al. Challenges of COVID-19 vaccination in patients with cancer. Natl Sci Open 2022; 1: 20220004. [Article] [CrossRef] [MathSciNet] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.